Successful treatment with thalidomide in a liver transplant recipient with giant esophageal ulcers
โ Scribed by Muslim Atiq; Guy W. Neff; Christos Argyropoulos; Mark Schroer; Nyingi Kemmer; Fredrick Weber; Joseph Buell
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 97 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20825
No coin nor oath required. For personal study only.
โฆ Synopsis
Idiopathic giant esophageal ulcers have been reported in transplant recipients, 1 however treatment options are limited primarily based upon the lack of successful therapies. There has been limited experience with using thalidomide in this population. We report our experience with using thalidomide in a liver transplant recipient who developed such lesions.
๐ SIMILAR VOLUMES
Pulmonary infections are a significant cause of morbidity and mortality after liver transplantation. Infections with methicillin-resistant Staphylococcus aureus (MRSA) have increased in the last 10 years. Mortality may exceed 80% in liver transplant recipients who develop MRSA pneumonia. A 57-year-o
A s liver transplantation in the alcoholic patient has become more common, the outcome in these patients has become important information in grounding the ethical debate that still surrounds this charged topic. Controversy has existed since alcoholic patients began receiving organ transplants in the
Disseminated infection with Bartonella spp with granulomatous hepatitis was diagnosed in a liver transplant recipient presenting with fever of unknown origin. Pathological findings on liver biopsy were atypical, with scant granulomas seen only after a second biopsy. The patient responded promptly to
Recent reports have documented human herpesvirus 6 (HHV-6) as a cause of high fever, bone marrow depression, and rash in liver transplant recipients in the absence of another known pathogen. We describe a 49-year-old liver transplant recipient who developed confusion, occipital headache, and involun